Visiongain Launches Report Examining the Potential in the $38bn Respiratory Inhalers Market

LONDON, May 30, 2019 /PRNewswire/ -- The global respiratory inhalers market is estimated to reach $38bn in 2023. In the respiratory Inhalers market the top three companies by revenue are GlaxoSmithKline, Boehringer Ingelheim and AstraZeneca, with 57.1% of the world market in 2018. How...

from PR Newswire: https://prn.to/2ELmekG